COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells
The new pandemic of SARS-CoV-2 Betacoronavirus, has spread worldwide, and infected millions of individuals causing the disease denominated of COVID-19. Further on flu symptoms, due to the high tropism of virus, has most been observed in the COVID-19 pathophysiology: acute heart failure, thromboembo...
Saved in:
| Main Authors: | Carla Longo de Freitas, Priscilla Yuri Okochi Alves da silva, Maria do Carmo Pinho Franco, Danilo Candido de Almeida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Unidad Central del Valle del Cauca
2021-12-01
|
| Series: | Magna Scientia UCEVA |
| Subjects: | |
| Online Access: | http://190.97.80.24:80/index.php/magnascientia/article/view/2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells
by: Carla Longo de Freitas, et al.
Published: (2021-12-01) -
Mesenchymal stromal cells from people with osteoporosis are fewer, and defective in both osteogenic and adipogenic capacity
by: Féaron C. Cassidy, et al.
Published: (2024-06-01) -
Mesenchymal stromal cells 2.0: thinking outside the box
by: Gabrielle A. Mandl, et al.
Published: (2025-08-01) -
IMPACT OF BONE MARROW-DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS ON SPEED OF POLYCAPROLACTONE AND POLYHYDROXYALKANOATE SCAFFOLDS BIODEGRADATION
by: L. V. Antonova, et al.
Published: (2012-05-01) -
Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?
by: Elke Niebergall-Roth, et al.
Published: (2025-08-01)